US tariff relief: Is it the best news for specialty drugs?
US tariff relief is a significant development for specialty drugs in India and 19 other countries, offering hope for better access and affordability.
US tariff relief is a significant development for specialty drugs in India and 19 other countries, offering hope for better access and affordability.
Tia Vincent GSK interview offers a clear insight into leadership and innovation at GSK. Discover her thoughts and experiences.